Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA
Russell Rosenberg, Brian Abaluck, Stephen Thein
Topics & Concepts
MedicinePlaceboOxybutyninInterquartile rangeAnesthesiaObstructive sleep apneaAtomoxetineApneaAdverse effectRandomized controlled trialClinical endpointSleep apneaHypopneaPolysomnographyInternal medicineOveractive bladderAttention deficit hyperactivity disorderPathologyAlternative medicinePsychiatryMethylphenidateObstructive Sleep Apnea ResearchSleep and related disordersSleep and Wakefulness Research